Equilibrium distributions of stochastic networks without detailed balance

We present results for the determination of the equilibrium microstate probability distribution of a class of strongly interacting systems obeying stochastic dynamics but without the necessity of detailed balance. The specific case of Ising systems is highlighted, with applications to non-symmetric synaptic neural networks and more general recurrent Boolean networks.     

Exact solutions of a nonlinear sigma-model in a curved space and the theory of magnetically ordered media with variable saturation magnetization

Stationary solitons are found to occur in two-dimensional media with a variable saturation magnetization whose square is a harmonic function of the coordinates. It is shown in this case that the Landau-Lifshits equation can be reduced to the integrable O(3) sigma-model in curved space. Some properties of the solutions obtained are discussed. Bibliography: 15 titles. Translated by V. D. Lipovskii.     

Input control in nonnegative matrix equations

In this paper we consider the nonnegative matrix system c_iA+u_iB=c_i+1 where the nonnegative matrix A is allowed to vary, within bounds. The cone control problem is to find a nonnegative matrix B such that if C_i is a nonnegative vector in a specified cone, then there is a nonnegative vector u_i such that c_i+1 is in that cone. We extend this problem to input control by finding a B such that the cone, generated by the rows of B, is as small as possible. Thus, the percent distribution of ∣u_iB∣ through the states of the sustem by u_iB is either constant or varies little.     

Phase diagram of multilayer magnetic structures

Multilayer ferromagnet-layered antiferromagnet (Fe/Cr) structures frustrated because of roughness of interlayer boundaries were studied by mathematical modeling methods. The phase diagram of a three-layer system (plotted as film thickness versus the degree of roughness of the interfaces) was obtained, and the order parameter distributions in each phase were determined. The character of phase transitions in this system was studied. The applicability range of the Slonczewski magnetic proximity model was determined.     

Contributions to the synthesis of some ferrocene-containing antibiotics

This Review discusses the synthesis and characterization by our Group of new antibiotics belonging to the class of penicillins, cephalosporins and rifamycins with ferrocenyl and 1, 1′-ferrocenilene residues in the molecule. As reactants for 6-aminopenicillanic acid (6-APA) and 7-aminocephalosporanic acid (7-ACA) the following were used: 1, 1-bis(chlorocarbonyl)ferrocene, ferrocenyl sulfochloride, 1, 1′-ferrocenylenedisulfochloride and thioglycolic acids S-modified with ferrocene. In the synthesis of rifamycins, the hydrazides of the thioglycolic acids, S-modified with ferrocene, were employed as nucleophilic agents. The synthesized intermediates were characterized by elemental analysis, TLC, IR, UV and ¹H NMR spectra. The characterization of new antibiotics was made by TLC, IR and UV spectral analysis. Biological activity was tested on Gram-negative and Gram-positive bacteria. Good activity is reported towards Gram-positive bacteria in the case of derivatives containing residues of thioglycolic acid S-modified with ferrocene, the antibacterial activity being similar to that of amoxicillin, carbenicillin and cephalothin. All compounds are inactive towards Gram-negative bacteria.     

Liquid crystal properties of some substituted pyrazines

A number of biphenyl, terphenyl analogues and ethynes which contain a pyrazine ring have been made and their liquid crystal transition temperatures, together with examples of birefringence measurements, are reported. All the 2,5-disubstituted pyrazine systems are liquid crystalline showing high birefringence values for the biphenyl and terphenyl analogues, whereas the 1,5-disubstituted systems are not liquid crystalline. The pyrazine ethyne systems exhibit very high birefringence values. X-ray diffraction has been used to identify the liquid crystal phases of 2-n-nonyloxy-5-(4'-propylbiphenyl-4-yl)pyrazine.